Nanosphere

• Four Analyst Upgrades that I Would Not Chase

  By Brian Nichols - March 4, 2013 | Tickers: ISRG, NSPH, SQNM, WNR

  An analyst’s call can be a major swing in momentum for a stock, creating a domino effect of revised outlooks and either buying or selling. Here are four stocks that traded with excessive volatility last Friday thanks to the notes issued by analysts; these are all calls worth noting that might not result in long-term gains.

  Company	Ticker	Firm	Call
  Western Refining	(NYSE: WNR)	Barclays	Overweight
  Nanosphere	(NASDAQ: NSPHmore »)

• Long-Term BioTech Play

  By Mohamed Mounir - October 2, 2012 | Tickers: CPHD, KERX, NSPH

  Ahh, the excitement of Biotech Investing! Buy a company that is currently in clinical trials, wait for the data to be released, and then watch your investment go through the roof, right?

  Guess again!

  Biotech will break your heart more often than not

  I learned that the hard way with Keryx (NASDAQ: KERX) and Aeterna Zentaris (NASDAQ: AEZS). The two companies were set to release the results of Phase III more »

• Three Technology ETFs Delivering Transparency and Cost Efficiency

  By Jeff Stouffer - September 4, 2012 | Tickers: AAPL, FSLR, HW, IBM, NSPH, PXN, RYT, XLK, WDC

  During the internet and telecommunications boom of the late 90’s, the concept of investment diversification in this area was nothing more than holding seven or more high technology funds. Concurrently exchange-traded funds were new and the concept of portfolio transparency was not in vogue. After the bursting of the bubble, then all of a sudden investors wanted to know more about the holdings of mutual funds. It became evident more »